精锋医疗-B(02675)今日在港股市场首日挂牌，盘中股价大幅上涨38.30%，成为市场焦点。
消息面上，精锋医疗此次IPO获得投资者热烈追捧，香港公开发售部分超额认购达1091.94倍，国际发售也获25.18倍认购。公司专注于手术机器人设计、开发及制造，是中国首家同时取得多孔腔镜、单孔腔镜及自然腔道手术机器人注册审批的企业。基石投资者包括腾讯旗下Huang River Investment、中东资本ADIA等14家机构，合计认购占比达48.68%。方正证券指出，国产腔镜手术机器人渗透率不足1%，市场空间广阔，政策支持叠加配置证放开，赛道热度持续攀升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.